{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:29:40Z","timestamp":1761823780993,"version":"3.37.3"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NIH National Institute of Neurological Diseases and Stroke","doi-asserted-by":"publisher","award":["R01 NS048353"],"award-info":[{"award-number":["R01 NS048353"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA122804"],"award-info":[{"award-number":["R01 CA122804"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["X81XWH-09-1-0086","W81XWH-11-1-0498","W81XWH-12-1-0164","W81XWH-14-1-0073","W81XWH-15-1-0193"],"award-info":[{"award-number":["X81XWH-09-1-0086","W81XWH-11-1-0498","W81XWH-12-1-0164","W81XWH-14-1-0073","W81XWH-15-1-0193"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"The Children's Tumor Foundation","doi-asserted-by":"publisher","award":["2014-04-001","2015-05-007"],"award-info":[{"award-number":["2014-04-001","2015-05-007"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ajpath.2015.10.023","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:21:53Z","timestamp":1451348513000},"page":"464-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Challenge of Cancer Genomics in Rare Nervous System Neoplasms"],"prefix":"10.1016","volume":"186","author":[{"given":"Steven L.","family":"Carroll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.10.023_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature09173","article-title":"Cross-species genomics matches driver mutations and cell compartments to model ependymoma","volume":"466","author":"Johnson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib4","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","article-title":"Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics","volume":"24","author":"Modena","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-012-0941-4","article-title":"A prognostic gene expression signature in infratentorial ependymoma","volume":"123","author":"Wani","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature13108","article-title":"Epigenomic alterations define lethal CIMP-positive ependymomas of infancy","volume":"506","author":"Mack","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11284","article-title":"Dissecting the genomic complexity underlying medulloblastoma","volume":"488","author":"Jones","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bpa.12171","article-title":"International Society Of Neuropathology\u2013Haarlem consensus guidelines for nervous system tumor classification and grading","volume":"24","author":"Louis","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib17","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib18","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.10.023_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-013-1218-2","article-title":"Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes","volume":"127","author":"Saratsis","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature11327","article-title":"Subgroup-specific structural variation across 1,000 medulloblastoma genomes","volume":"488","author":"Northcott","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas","volume":"123","author":"Kool","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0011-3840(96)80013-X","article-title":"Soft tissue sarcomas","volume":"33","author":"Lewis","year":"1996","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.ajpath.2015.10.023_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-011-0928-6","article-title":"Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms","volume":"123","author":"Carroll","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2015.10.023_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/humu.20493","article-title":"Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption","volume":"28","author":"Wimmer","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajpath.2015.10.023_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/gcc.20289","article-title":"Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients","volume":"45","author":"Wimmer","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/neuonc\/nou004","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/NEN.0000000000000201","article-title":"Classic Ras proteins promote proliferation and survival via distinct phosphoproteome alterations in neurofibromin-null malignant peripheral nerve sheath tumor cells","volume":"74","author":"Brossier","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1634\/theoncologist.10-8-565","article-title":"Development of farnesyl transferase inhibitors: a review","volume":"10","author":"Appels","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.ajpath.2015.10.023_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.10.023_bib32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.18632\/oncotarget.1609","article-title":"Co-targeting the MAPK and PI3K\/AKT\/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity","volume":"5","author":"Watson","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2015.10.023_bib33","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.10.023_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen","year":"2008","journal-title":"Curr Biol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib35","first-page":"996","article-title":"Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues","volume":"117","author":"Hirota","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajpath.2015.10.023_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jnr.490370314","article-title":"Role for the stem cell factor\/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis","volume":"37","author":"Ryan","year":"1994","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib37","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1172\/JCI19195","article-title":"Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+\/- mast cells","volume":"112","author":"Yang","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2015.10.023_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.191.1.181","article-title":"Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in\u00a0vivo","volume":"191","author":"Ingram","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.10.023_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.194.1.57","article-title":"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in\u00a0vivo and in\u00a0vitro","volume":"194","author":"Ingram","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.10.023_bib40","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/ddl165","article-title":"Nf1+\/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling","volume":"15","author":"Yang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib41","first-page":"325","article-title":"Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes","volume":"11","author":"Kim","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.10.023_bib42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1523-1747.1999.00609.x","article-title":"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts","volume":"112","author":"Atit","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib43","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0002-9440(10)61148-0","article-title":"Altered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1","volume":"160","author":"Korkiamaki","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib44","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0002-9440(10)65504-6","article-title":"Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas","volume":"155","author":"Kourea","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib45","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0002-9440(10)65507-1","article-title":"Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A\/p16 inactivation","volume":"155","author":"Nielsen","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00428-001-0550-4","article-title":"Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors","volume":"440","author":"Mawrin","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ajpath.2015.10.023_bib47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-07-1305","article-title":"High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization","volume":"14","author":"Mantripragada","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib48","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.1073\/pnas.0910398106","article-title":"PTEN dosage is essential for neurofibroma development and malignant transformation","volume":"106","author":"Gregorian","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.10.023_bib49","doi-asserted-by":"crossref","first-page":"e47595","DOI":"10.1371\/journal.pone.0047595","article-title":"Impaired Pten expression in human malignant peripheral nerve sheath tumours","volume":"7","author":"Bradtmoller","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.10.023_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/neuonc\/nou140","article-title":"Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis","volume":"17","author":"Danielsen","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib51","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1158\/1078-0432.CCR-11-1707","article-title":"Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment","volume":"17","author":"Yang","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/64.1.1","article-title":"Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling","volume":"64","author":"Carroll","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/glia.20482","article-title":"Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy","volume":"55","author":"Nebesio","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2015.10.023_bib54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2013.01.053","article-title":"CXCR4\/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors","volume":"152","author":"Mo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib55","doi-asserted-by":"crossref","first-page":"e11858","DOI":"10.1371\/journal.pone.0011858","article-title":"The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment","volume":"5","author":"Zietsch","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.10.023_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.2870140103","article-title":"Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas","volume":"14","author":"Forus","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib57","first-page":"4778","article-title":"Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis","volume":"56","author":"Lothe","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<362::AID-GCC8>3.0.CO;2-Q","article-title":"Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization","volume":"25","author":"Mechtersheimer","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ijc.2910610609","article-title":"Cytogenetic findings in malignant peripheral nerve sheath tumors","volume":"61","author":"Mertens","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<31::AID-PATH505>3.0.CO;2-#","article-title":"Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group","volume":"190","author":"Mertens","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A","article-title":"Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway","volume":"26","author":"Berner","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2264(199907)25:3<205::AID-GCC2>3.0.CO;2-B","article-title":"Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant","volume":"25","author":"Schmidt","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-3835(00)00426-2","article-title":"Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease","volume":"155","author":"Schmidt","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajpath.2015.10.023_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(01)00393-4","article-title":"Cytogenetic characterization of six malignant peripheral nerve sheath tumors: comparison of karyotyping and comparative genomic hybridization","volume":"128","author":"Schmidt","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-4598-7-48","article-title":"DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH","volume":"7","author":"Kresse","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib66","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ng.3116","article-title":"Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib67","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib68","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/0008-5472.CAN-05-3330","article-title":"Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues","volume":"66","author":"Miller","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-013-1185-4","article-title":"Relevance of MPNST cell lines as models for NF1 associated-tumors","volume":"114","author":"Pasmant","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib70","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/glia.20776","article-title":"How does the Schwann cell lineage form tumors in NF1?","volume":"56","author":"Carroll","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2015.10.023_bib71","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature05886","article-title":"Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers","volume":"447","author":"Maser","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<171::AID-IJC5>3.0.CO;2-S","article-title":"Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas","volume":"83","author":"Plaat","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2015.10.023_bib73","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-10-4563","article-title":"Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis","volume":"71","author":"Young","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nmeth.1597","article-title":"Next-generation sequencing to generate interactome datasets","volume":"8","author":"Yu","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2015.10.023_bib75","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature05886","article-title":"Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers","volume":"447","author":"Maser","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.10.023_bib76","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nmeth.1613","article-title":"Computational methods for transcriptome annotation and quantification using RNA-seq","volume":"8","author":"Garber","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2015.10.023_bib77","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1158\/0008-5472.CAN-10-3597","article-title":"Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model","volume":"71","author":"Endersby","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib78","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2010-11-10-r100","article-title":"Somatic structural rearrangements in genetically engineered mouse mammary tumors","volume":"11","author":"Varela","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib79","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","article-title":"Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene","volume":"125","author":"Kim","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib80","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","article-title":"Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach","volume":"125","author":"Zender","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2008.03.021","article-title":"Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks","volume":"133","author":"Uren","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib82","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1126\/science.1163040","article-title":"A transposon-based genetic screen in mice identifies genes altered in colorectal cancer","volume":"323","author":"Starr","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib83","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1158\/0008-5472.CAN-09-1135","article-title":"A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice","volume":"69","author":"Dupuy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.10.023_bib84","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2015.10.023_bib85","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib86","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2013 and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib88","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib89","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","article-title":"Mouse tumor model for neurofibromatosis type 1","volume":"286","author":"Vogel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.10.023_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2008.01.003","article-title":"The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells","volume":"13","author":"Joseph","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib91","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/sj.onc.1205632","article-title":"Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype","volume":"21","author":"King","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.10.023_bib92","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1038\/sj.onc.1208730","article-title":"Activation of the neuregulin-1\/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors","volume":"24","author":"Stonecypher","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.10.023_bib93","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/neuonc\/nor226","article-title":"The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells","volume":"14","author":"Kohli","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib94","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/glia.20866","article-title":"Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells","volume":"57","author":"Eckert","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2015.10.023_bib95","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1523\/JNEUROSCI.23-19-07269.2003","article-title":"Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor beta3 in myelinating Schwann cells","volume":"23","author":"Huijbregts","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2015.10.023_bib96","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ajpath.2012.11.017","article-title":"Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis","volume":"182","author":"Kazmi","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib97","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-013-1209-3","article-title":"Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis","volume":"127","author":"Brosius","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib98","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ccr.2004.10.016","article-title":"Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis","volume":"7","author":"Ling","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2015.10.023_bib99","doi-asserted-by":"crossref","first-page":"620834","DOI":"10.1155\/2012\/620834","article-title":"Conditional inactivation of Pten with EGFR overexpression in Schwann cells models sporadic MPNST","volume":"2012","author":"Keng","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.ajpath.2015.10.023_bib100","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.ajpath.2014.04.006","article-title":"Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis","volume":"184","author":"Rahrmann","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.10.023_bib101","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/ng.2641","article-title":"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis","volume":"45","author":"Rahrmann","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2015.10.023_bib102","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/CCO.0000000000000038","article-title":"Prevalence and clinical implications of chromothripsis in cancer genomes","volume":"26","author":"Kloosterman","year":"2014","journal-title":"Curr Opin Oncol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015006458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015006458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:49:32Z","timestamp":1615358972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944015006458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002944015006458"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.023","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Challenge of Cancer Genomics in Rare Nervous System Neoplasms","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}